Kalyan C. Nallaparaju

Author

The University of Texas MD Anderson Cancer Center

Also Known As

Kalyan C Nallaparaju, Kalyan C. Nallaparaju, Kalyan Nallaparaju, Kalyan C. Nallaparaju

Publications

510

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Tsinghua University

About

Kalyan C. Nallaparaju is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, immune regulation, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	229
2	Immunology	2	2	229
3	Allergy	1	1	98
4	Cell Biology	1	1	98
5	Gastroenterology	1	1	98

Kalyan C. Nallaparaju

Publications

499

Citations

H-Index

Page 1

	Year	Citations
Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation Joseph M. Reynolds, Young‐Hee Lee, Yun Shi, Immunity InflammationCytokineAutoimmune DiseaseMucosal ImmunologyImmune Regulation	2015	131
Genome-wide Analysis Identifies Bcl6-Controlled Regulatory Networks during T Follicular Helper Cell Differentiation Xindong Liu, Huiping Lu, Tingting Chen, Cell Reports	2016	124
Cutting Edge: Regulation of Intestinal Inflammation and Barrier Function by IL-17C Joseph M. Reynolds, Gustavo Martínez, Kalyan C. Nallaparaju, The Journal of Immunology Chronic Inflammatory DiseasesIntestinal InflammationMicrobial PathogensImmune RegulationImmunology	2012	98
The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development Haiyan S. Li, Cliff Y. Yang, Kalyan C. Nallaparaju, Blood	2012	85
MAPK Phosphatase 7 Regulates T Cell Differentiation via Inhibiting ERK-Mediated IL-2 Expression Yongliang Zhang, Kalyan C. Nallaparaju, Xin Liu, The Journal of Immunology	2015	30
Evasion of IFN-γ Signaling by Francisella novicida Is Dependent upon Francisella Outer Membrane Protein C Kalyan C. Nallaparaju, Jieh‐Juen Yu, Stephen A. Rodriguez, PLoS ONE	2011	19
Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth <i>In Vivo</i> Kai Schiemann, Natalya Belousova, Armine Matevossian, Molecular Cancer Therapeutics	2024	12

Page 1